Viewing StudyNCT00238472



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00238472
Status: COMPLETED
Last Update Posted: 2012-04-27
First Post: 2005-10-12

Brief Title: A Pilot Study to Evaluate the Effects of Nateglinide vs Glibenclamide on Renal Hemodynamics and Albumin Excretion
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
nateglinide View
Type 2 diabetes View